JAMIE BOHLER: Open Payments
NPI 1346965472 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 13 payments from 5 companies in 2025. Trend: 2023 $204 · 2024 $398 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $129 |
| Biogen, Inc. | 5 | $109 |
| Exeltis, USA Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| Organon LLC | 2 | $12 |
Products named: MYFEMBREE, ZURZUVAE, SLYND, Veozah, NEXPLANON.
Industry payments across GA — which companies pay providers there.
